EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
Top Cited Papers
- 19 September 2003
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (20) , 11606-11611
- https://doi.org/10.1073/pnas.1933744100
Abstract
The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling cellular memory and has been linked to aggressive prostate cancer. Here we investigate the functional role of EZH2 in cancer cell invasion and breast cancer progression. EZH2 transcript and protein were consistently elevated in invasive breast carcinoma compared with normal breast epithelia. Tissue microarray analysis, which included 917 samples from 280 patients, demonstrated that EZH2 protein levels were strongly associated with breast cancer aggressiveness. Overexpression of EZH2 in immortalized human mammary epithelial cell lines promotes anchorage-independent growth and cell invasion. EZH2-mediated cell invasion required an intact SET domain and histone deacetylase activity. This study provides compelling evidence for a functional link between dysregulated cellular memory, transcriptional repression, and neoplastic transformation.Keywords
This publication has 35 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Role of Histone H3 Lysine 27 Methylation in Polycomb-Group SilencingScience, 2002
- Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor ComplexCell, 2002
- Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb SitesCell, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Do we need prognostic factors in nodal-negative breast cancer?: Arbiter:European Journal Of Cancer, 2000
- The Hallmarks of CancerCell, 2000
- Stabilization of Chromatin Structure by PRC1, a Polycomb ComplexCell, 1999